Core Viewpoint - Zhuhai Saiwei has withdrawn its application for an initial public offering (IPO) on the Shenzhen Stock Exchange's Growth Enterprise Market, leading to the termination of the review process by the exchange [2]. Group 1: Company Overview - Zhuhai Saiwei primarily engages in the research, production, and sales of lithium-ion battery electrolytes [2]. - The company initially planned to issue no more than 23.090278 million shares, accounting for at least 25% of the total share capital post-issue [2]. Group 2: Fundraising and Project Details - The company aimed to raise 1 billion yuan (100,000 million yuan) for several projects, including: - A project in Huainan to produce 200,000 tons of secondary lithium-ion battery electrolytes and supporting raw materials (Phase I) with a total investment of 1.504 billion yuan (150,400 million yuan) [3]. - A research and development center in Hefei with a total investment of 100 million yuan (10,000 million yuan) [3]. - Supplementing working capital with an investment of 300 million yuan (30,000 million yuan) [3]. - The total investment for all projects was 1.904 billion yuan (190,400 million yuan) [3].

Group 1 - The seminar titled "Guide to the Growth of Securities Researchers: Work Processes and Career Advancement" was held for 105 first-year graduate students in Financial Technology at Jinan University Shenzhen Campus, aimed at bridging academic theory and industry practice [1] - The speaker, Luo Guo from the headquarters of China Merchants Securities, outlined the core functions, daily workflows, and career paths of securities researchers, differentiating between sell-side and buy-side researchers [3] - The seminar provided practical methods for fundamental research from macro, industry, and company perspectives, covering information collection, financial modeling, valuation methods, and report writing standards [3] Group 2 - Luo emphasized the importance of both hard skills (economics, accounting, finance, legal regulations, and computer applications) and soft skills (logical thinking, information retrieval, abstract modeling, communication, and client relationship maintenance) for career development in securities research [3] - The typical growth path from intern to chief researcher was presented, highlighting that report quality, roadshow effectiveness, and market reputation are key factors for career advancement [3] - The seminar effectively enhanced the understanding of the securities research profession among the graduate students and clarified their academic and career planning [4] Group 3 - China Merchants Securities aims to leverage its professional advantages to contribute to national financial education through various forms such as course delivery and practical sharing, promoting the integration of theory and practice [4]

Core Insights - The 2026 industry trend update focuses on AI computing hardware, edge AI, physical AI (autonomous driving, robotics, brain-computer interfaces), AI large models and applications, and commercial aerospace [2][6][8] - The CES 2026 event in Las Vegas highlighted a shift from traditional consumer hardware to AI infrastructure and industrial intelligence, covering various sectors including artificial intelligence, robotics, automotive technology, digital health, and quantum technology [2][7][18] Market Performance - The A-share market has continued its upward trend into 2026, driven by significant net inflows of financing, with a total of 857.8 billion yuan in the first four trading days of January [3][4][8] - The average guarantee ratio of margin trading has increased due to rising stock prices, indicating strong market confidence [3][8] Industry Trends - AI computing hardware advancements include NVIDIA's launch of the next-generation Rubin computing platform, which integrates various components for enhanced performance and cost efficiency [9][21][24] - Edge AI is gaining traction with products like ByteDance's "Doubao" AI glasses entering the market, indicating a shift towards productization in consumer electronics [10][11] - Physical AI developments include NVIDIA's Alpamayo autonomous driving ecosystem, which aims to enhance vehicle decision-making capabilities through multi-step reasoning [12][34][36] Funding and Investment - Significant net inflows in financing have been observed, while ETF redemptions have occurred, indicating a mixed sentiment in the investment landscape [4][8] - Meta's acquisition of AI startup Manus for over $2 billion reflects a strategic move to enhance its AI capabilities and address application gaps [4][14] Valuation Metrics - The overall valuation level of A-shares has increased, with the Wind All A Index PE (TTM) at 18.15, indicating a relatively high valuation compared to historical levels [4][8] Sector Recommendations - The report recommends focusing on cyclical and technology sectors, particularly in the context of the upcoming spring market dynamics and annual report previews [3][8] - Key sectors to watch include power equipment, machinery, non-bank financials, electronics, and basic chemicals, with an emphasis on AI hardware, robotics, and AI applications [8][12]

Core Viewpoint - Ecovision Optoelectronics (688610.SH) is currently trading at 65.94 yuan, reflecting a decline of 1.85% and is in a state of breaking its initial public offering (IPO) price [1] Group 1: IPO Details - Ecovision Optoelectronics was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 19, 2023, with a public offering of 17 million shares at an issue price of 73.33 yuan per share [1] - The total amount raised from the IPO was 1.24661 billion yuan, with a net amount of 1.13511 billion yuan after deducting issuance costs [1] - The final net amount raised exceeded the original plan by 15.66 million yuan, as the company initially aimed to raise 1.11944 billion yuan [1] Group 2: Fund Allocation - The funds raised are intended for the construction of the company's headquarters industrial imaging core components project, the establishment of a machine vision research and development center, and to supplement working capital [1] Group 3: Issuance Costs - The total issuance costs for the IPO amounted to 111.49 million yuan, with the underwriting fees for the lead underwriter, China Merchants Securities Co., Ltd., being 89.52 million yuan [1]

Group 1 - The core viewpoint of the article is that the education sector has a promising outlook driven by innovations in AI technology and defensive growth [1] - The report highlights that Duolingo and New Oriental are the top picks, maintaining "buy" ratings with target prices of $347 and $70 respectively [1] - The article emphasizes that the continuous innovation of AI in education is leading to a differentiated competitive landscape among market participants [1] Group 2 - The comprehensive development of model capabilities, systematic content, emotional support, and generalized learning scenarios is identified as a future trend in the education industry [1]

Core Insights - The Chinese 3D printing market is expected to reach 70 billion by 2025, growing at a rate of 30%, with significant contributions from industrial machinery (20%), aerospace (17%), automotive (14%), and consumer electronics (13%) [1][2] - The industry is transitioning from niche applications to mainstream adoption, driven by advantages such as customization, reduced R&D cycles, and cost-effective small-batch production [1][2] - The commercial aerospace sector is identified as a key growth area, focusing on the demand for reusable rockets and satellite delivery [3] Industry Overview - The global 3D printing market is projected to reach 21.9 billion in 2024, with a growth rate of 9.31%, where non-metal technologies, particularly FDM, dominate with a 61.6% share, while metal technologies are led by SLM with an 89.4% share [2] - In China, the 3D printing production volume is expected to grow by 40.5% year-on-year from January to September 2025, with exports reaching 4.48 million units (+29.6%) and export value at 9.866 billion (+31.9%) [2] Market Segmentation - The industrial segment is seeing a rise in China's market share, increasing from 8.2% in 2009 to 11.5% in 2024, with the U.S. holding 31% and Germany at 8% [3] - In the metal 3D printing sector, Germany's EOS leads with a 41% market share, while China's Platinum Tech has risen to 20%, ranking second globally [3] Consumer Market Dynamics - The global consumer 3D printing market is expected to reach 4.1 billion in 2024, growing by 32%, with a shipment volume of 4.1 million units (+17%) and a total installed base of 15.8 million units (+15%) [4] - The demand for personalized and limited-edition products is driving growth, while companies like拓竹 and创想三维 are making devices more user-friendly and affordable, enhancing market accessibility [4] Key Industry Players - Key players in the metal materials segment include Youyan Powder Materials and Srey New Materials, while polymer materials are represented by Jialian Technology [5] - Leading companies in the industrial-grade sector include Platinum Tech and Huazhu High-Tech, which are closely tied to aerospace and defense industries [5] - In the consumer segment, 创想三维 is noted for its high growth potential as it prepares for an IPO [5]

Group 1 - The core viewpoint of the report is that Xianruida Medical-B (06669) is given a "strong buy" investment rating due to its innovative capabilities and product strength, supported by the global platform of its controlling shareholder, Boston Scientific, which enhances performance certainty through collaboration in overseas expansion and new product development [1] Group 2 - Xianruida is a leading domestic company focused on providing comprehensive vascular intervention solutions, having launched the first knee and below DCB products in China, and is positioned at the forefront of the peripheral intervention field [1][2] Group 3 - The company has established a multi-technology platform since 2011, developing drug-coated balloon (DCB) and percutaneous transluminal angioplasty (PTA) products, achieving a comprehensive layout in the peripheral intervention field with over 30 listed products by H1 2025, covering vascular surgery, cardiology, nephrology, and neurology [2] Group 4 - The product lineup is structured in a "pyramid" model, with mature products like DCB and PTA balloons being the main revenue source, while growth products such as peripheral suction systems and radiofrequency ablation systems are expected to drive future revenue growth [3] Group 5 - A new three-year cooperation agreement was signed with Boston Scientific for 2026-2028, which includes global commercialization, product manufacturing, and R&D support, with projected sales to Boston Scientific reaching up to $30 million, $62 million, and $78 million in the respective years [4]

Core Viewpoint - The report from China Merchants Securities initiates coverage on Xianruida Medical-B (06669) with a "strong buy" rating, highlighting the company's innovative capabilities and product strength, as well as the performance certainty brought by the collaboration with its controlling shareholder, Boston Scientific, in overseas expansion and new product development [1]. Company Overview - Xianruida is a leading domestic innovative medical device platform focused on providing comprehensive vascular intervention solutions, having launched the first knee and below DCB products in China, and is positioned at the forefront of the peripheral intervention field [2]. Technology and Product Development - The company has been engaged in the R&D of PTA and DCB products since 2011, establishing a multi-technology platform that includes drug-coated technology, radiofrequency ablation technology, polymer material technology, and aspiration platform technology, achieving a comprehensive layout in vascular intervention with over 30 listed products by H1 2025, covering vascular surgery, cardiology, nephrology, and neurology [3]. Product Portfolio and Growth - The company has built a "pyramid" product group since the launch of its core knee DCB product in China in 2016, leading to steady revenue growth: 1. Mature products, including DCB and PTA balloons, are the main revenue sources, with the company holding the top market share in the domestic peripheral DCB sector and securing multiple procurement bids [4]. 2. Growth-stage products, such as peripheral aspiration systems and radiofrequency ablation systems, are in early volume expansion and are expected to contribute significantly to future revenue growth [4]. 3. The pipeline includes in-development projects like lower limb rapamycin DCB and IVL systems, covering mainstream departments and serving as a core source for medium to long-term growth [4]. Collaboration with Boston Scientific - In February 2023, Boston Scientific became the controlling shareholder of Xianruida with a 65% stake and signed a memorandum of understanding in June 2023. A new three-year cooperation agreement was signed for 2026-2028, which includes: 1. Global commercialization, sharing Boston Scientific's global channel resources, with projected sales to Boston Scientific capped at $30 million, $62 million, and $78 million for 2026, 2027, and 2028 respectively [5]. 2. Product manufacturing, providing OEM services with projected transaction amounts of $1 million, $1 million, and $3 million for the same years [5]. 3. Product R&D, with mutual support and CSO services [5].

Group 1 - The core viewpoint of the report is that the integration of AI and education is leading to a differentiated competitive landscape among market participants [1] - The comprehensive development of model capabilities, systematic content, emotional support, and generalized learning scenarios is expected to be a future trend [1] - Leading companies in China's education and training sector are enhancing their market share through superior content, services, and financial advantages [1] Group 2 - The report anticipates a balanced growth in revenue and profitability for leading education companies, projecting a 16% year-on-year increase in revenue and an 18% increase in core net profit by 2026 [1] - The average core net profit margin is expected to expand from 6% to 7% by 2026 [1] - The education sector is viewed positively for its resilient growth and expansion opportunities, with AI technology expected to further drive growth [1] Group 3 - The preferred investment choices highlighted in the report are Duolingo (DUOL.US) and New Oriental (EDU.US) [1]

2021年4月27日该行披露的2020年度募集资金存放与实际使用情况的专项报告显示，经中国银行保 险监督管理委员会青岛监管局《青岛银保监局关于青岛农村商业银行公开发行A股可转换公司债券相关 事宜的批复》(青银保监复[2019]502号)及中国证券监督管理委员会《关于核准青岛农村商业银行股份有 限公司公开发行可转换公司债券的批复》(证监许可[20201440号)核准，青农商行于2020年8月25日公开 发行票面金额为人民币5,000,000,000.00元可转换公司债券。本次发行可转债募集资金总额为人民币 5,000,000,000.00元，扣除发行费用人民币34,664,150.95元(不含增值税)后，实际募集资金金额为人民币 4,965,335,849.05元。 经计算，青农商行首发及可转债累计融资金额72亿元。 (责任编辑：魏京婷) 中国经济网北京1月8日讯 今日，青农商行(002958.SZ)收报3.09元，跌幅0.64%，总市值 171.67亿 元。目前该股处于破发状态。 青农商行于2019年3月26日在深交所上市，发行价格为3.96元/股。2019年4月4日，青农商行盘中创 下上市以来最高价10.9 ...